Printer Friendly
The Free Library
19,266,353 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Hepatitis B antibody carriers should be deferred. (Blood bank news).


A recent study indicates that donors who have antibodies to hepatitis B Core antigen hepatitis B core antigen
n. Abbr. HBcAg
A core protein antigen of the hepatitis B virus found on the Dane particle and also in hepatocyte nuclei in hepatitis B infections.
 (anti-HBc) but are free of hepatitis B surface antigen hepatitis B surface antigen
n. Abbr. HBsAg
An antigen derived from the surface of the hepatitis B virus that is present in the blood in active hepatitis B infection. Also called Australia antigen.
 (HBsAg) may still be infectious and should be deferred. The study's findings indicated that 11 of 50 HBsAg-negative, anti-HBc-positive persons studied still had the virus present in their systems as immune complexes, and eight others tested positive for the virus's DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
, despite testing negative for the virus itself.
COPYRIGHT 2002 Nelson Publishing
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Medical Laboratory Observer
Article Type:Brief Article
Geographic Code:1USA
Date:Jan 1, 2002
Words:71
Previous Article:Study finds hemochromatosis patient's blood is safe. (Blood bank news).(for donation)(Brief Article)
Next Article:Testing for genetic predisposition to venous thrombosis.
Topics:



Related Articles
Hepatitis agents defined, cultured.
Protecting employees from job-related diseases.
New hepatitis virus, test found.
Chimp test for oral hepatitis B vaccine.
Commonly asked questions about hepatitis B vaccination.
Is your hepatitis B vaccine really protecting you?
Hepatitis C Virus RNA Viremia in Central Africa.
Time and Events Schedule for the Main SMART Study.(research on the long-term effects of antiretroviral therapy)(Brief Article)
FDA approves Roche's NAT for screening cadaveric organ and tissues for Hepatitis B virus infection.(Roche Diagnostics introduces Cobas AmpliScreen...
Detecting hepatitis B surface antigen mutants.(PERSPECTIVE)

Terms of use | Copyright © 2010 Farlex, Inc. | Feedback | For webmasters | Submit articles